ASMI’s beat was real, but the order book says the market should not pay peak multiples for a trough-proof story

The print changes the ASMI debate because the surprise came where investors were least prepared, but the forward signal came where they most wanted confirmation. What was priced in was a mid-cycle pause with premium margins: the street sat at €814.9 million of revenue and €4.74 of EPS, already giving the company credit for process-control scarcity and leading-node exposure. What actually surprised was the magnitude of the top-line beat, with €934.8 million versus €814.9 million, a +14.7% surprise that makes the reported quarter look much better than the order and guidance data beneath it. The EPS beat was less forceful at €4.90 versus €4.74, or +3.4%, which matters because it says the upside did not fully translate into incremental earnings power on the street-comparison basis. The variant perception is therefore not that ASMI is weak; it is that the market may be over-reading the revenue beat as a demand acceleration while under-reading the Q4 guide and orders as evidence that the path to the next node-driven leg is uneven.

That distinction is unusually important in this quarter because the company’s own call basis and the street-comparison print do not use the same top-line figure. On the call, Paul Verhagen framed the quarter more modestly: “The revenue in the third quarter of '25 amounted to EUR 800 million, up 8% year-on-year at constant currency.” That wording matters because management chose constant-currency growth language rather than celebrating the larger street-comparison surprise, and the reported-history series also shows Q3 FY2025 revenue at €798.2 million with a 51.9% gross margin. The best reading is that ASMI delivered a better-than-modeled quarter, but not one that resets the slope of the business by itself. Investors who bought the beat alone are implicitly assuming the order book will catch up; investors who focus only on the Q4 guide risk missing that gross margin is still above the peer set and above ASMI’s own older range.

The financial trajectory supports that mixed interpretation because revenue has moved from a 2023 trough toward an elevated 2025 plateau, while margin has held the low-50s band rather than collapsing with volume. The relevant shape is not a straight-line ramp; revenue climbed into the €800 million area and then rolled into a Q4 FY2025 point of €691.8 million before rebounding to €862.5 million in Q1 FY2026 in the historical table. Gross margin is the more durable piece of the story: Q3 FY2025 held at 51.9%, almost unchanged from 51.8% in Q2 FY2025, and above 49.4% in Q3 FY2024. That is why the print is not bearish despite the order softness. The installed base, product mix, and leading-node exposure are doing real work, but the market should separate margin quality from revenue linearity. A high-quality gross margin does not make a lumpy orders cycle disappear.

The capacity story explains the margin guide, because management is telling investors that mix, not utilization alone, is the swing factor into year-end. Verhagen’s most useful hedge was not a broad macro caveat but a specific mix warning: “As mentioned in the press release, we expect a less stable mix in the fourth quarter, which should bring the gross margin to around 51% for the full year.” The commitment is narrow but investable. If full-year gross margin stays around 51%, ASMI has protected the profitability thesis even with Q4 revenue guided to €630 million to €660 million. The risk is that investors capitalize that margin as if it is immune to mix, when management explicitly tied the next move to less stable mix. That puts the premium valuation debate on firmer footing: the company is proving process intensity, but not yet proving that every quarter of gate-all-around transition spending will arrive smoothly.

Orders are the cleanest pushback to a simple “beat and raise” interpretation, and they deserve more weight than the headline surprise. Verhagen said, “Our new orders amounted to EUR 637 million, a decrease of 7% compared to the second quarter and a decrease of 7% compared to the third quarter of last year at constant currency.” That single sentence carries the core tension: orders were below the quarter’s revenue base on the company’s own call basis, and management guided Q4 revenue lower at €630 million to €660 million. A bull can argue this is digestion before the next logic-node step-up; a bear can argue the order book is telling you the revenue beat was pull-forward or shipment timing. My read is closer to the bull case on multi-year structure but closer to the bear case on near-term estimate revision. The stock should not be rewarded as though Q3 proved a new run rate, because the company’s own next-quarter guide says otherwise.

The second-order read-through is most constructive for the leading-edge customers, but it is not equally constructive across time horizons. For TSMC, Samsung, and Intel, ASMI’s ALD, epitaxy, and PEALD exposure means this quarter confirms that front-end process intensity remains the scarce part of the wafer-fab-equipment stack. The magnitude that matters is management’s view that front-end-of-line ALD layers rise from 50% at the 2-nanometer node to 60% at the 1.4 nanometer node, which supports ASMI content per wafer start at those customers rather than just wafer-start growth. The near-term caution is China: equipment sales from China are expected to be approximately 30% of total ASM revenue in full year 2025, and management quantified the export-control impact on total annualized sales as around 1% to 2% negative. For TSMC, Samsung, and Intel, that means ASMI’s structural content story is more tied to leading-node ramps than China catch-up spend; for ASMI, that means the next leg has to come from node transitions rather than a broad China equipment cycle.

The peer comparison sharpens the point that ASMI’s premium is earned on margin, not on near-term growth dominance. In the latest peer table, Tokyo Electron shows +10.6% revenue YoY with a 46.8% gross margin, while the broad group includes growth as high as +28.2% and margins as low as 25.0%. ASMI’s Q3 FY2025 gross margin of 51.9% is the standout, but its reported revenue YoY of +2.5% in the history table is not. That is the right way to frame relative positioning: ASMI is not currently the fastest top-line comp in wafer-fab equipment, but it has a margin profile that supports a differentiated multiple if orders stabilize. The risk to relative performance is therefore specific, not generic: if investors can buy faster revenue growth elsewhere in the group while ASMI’s orders remain at €637 million, ASMI’s multiple needs the gate-all-around narrative to do more of the work.

The call tone helps explain why the stock may have reacted better than the order data alone would justify, but it also reveals a change in delivery that investors should treat carefully. The tone history shows Q3 FY2025 sentiment at 0.19 and guidance_tone at 0.39, both improved from the prior call’s weaker setup, while ai_optimism reached 0.67. Yet tone_confidence was only 0.36 and uncertainty remained elevated at 63.6, so the delivery was not a clean all-clear. The most interesting call-over-call pattern in the table is that Q1 FY2026 later showed sentiment at 0.36 and qa_sentiment at 0.38, while guidance_tone slipped by -0.06 versus Q4 FY2025. That kind of configuration, higher Q&A comfort but less upbeat guidance language, is consistent with a management team that has conviction in the structural story while still managing near-term cadence tightly.

That tone pattern matters because ASMI used the event to keep the long-range framework alive while refusing to overpromise the next quarter. Management reiterated a 2030 revenue ambition of more than €5.7 billion and a CAGR of at least 12% from 2024 through 2030, while also raising the gross margin target to 47% to 51%. Those numbers are not decorative; they are the reason the stock can look through a Q4 revenue guide that starts at €630 million. The issue is timing. If 2025 revenue growth is close to 10% at constant currencies, as Hichem M'Saad said, then the market is being asked to bridge a near-term orders dip to a multi-year process-intensity curve. That bridge is plausible because gate-all-around and 1.4 nanometer increase ASMI’s served opportunity, but plausible is not the same as de-risked. The next few prints must show whether the order book follows the technology roadmap.

Cash generation keeps the downside from becoming a balance-sheet story, which is another reason not to turn cautious on the franchise. Verhagen said free cash flow excluding earn-outs was €239 million in Q3 and €628 million in the first 9 months, while full-year CapEx is still expected at €200 million to €250 million. That combination tells PMs the company is funding capacity and R&D without stretching the model. It also matters for suppliers and customers in practical terms: with no named suppliers in the data pack and a CapEx envelope that is not expanding beyond €250 million, this print does not signal a sudden upstream capacity scramble. For customers, it signals continuity of tool availability rather than a capacity shock. ASMI’s internal investment profile supports the leading-node roadmap, but it does not suggest management is seeing enough immediate demand to push CapEx above the stated range.

The cleanest investment conclusion is that the stock should be owned for content growth but traded with discipline around order conversion. The market may be missing that the Q3 revenue beat and the Q4 guide can both be true: ASMI can have a structurally richer process position and still be entering a lower revenue quarter. That is why the best long thesis is not “Q3 was a blowout”; it is that ASMI is defending 51.9% gross margin while positioning for ALD layer growth from 50% to 60% across node transitions. The bear case is also not “the cycle is broken”; it is that new orders of €637 million and Q4 revenue guidance of €630 million to €660 million leave little evidence of an immediate acceleration. The stock deserves a premium to less profitable wafer-fab-equipment peers, but the next leg in that premium requires backlog evidence, not another restatement of the 2030 framework.

What to watch next quarter is therefore precise. First, Q4 revenue must land inside or above the €630 million to €660 million range; a result below that range would break the argument that Q3 timing merely preceded a controlled digestion. Second, full-year gross margin needs to stay around 51%, because management explicitly tied Q4 mix volatility to that level; a material miss would undermine the margin-quality leg of the thesis. Third, new orders need to move meaningfully above €637 million to confirm that leading-edge customers are converting node roadmaps into near-term tool demand. Finally, listen on the next call after 2025-10-29 for whether management repeats close to 10% constant-currency growth language for 2025 and whether China remains approximately 30% of total ASM revenue. If orders recover while margin stays near the raised 47% to 51% target band, the market is underpricing the node-transition compounding; if orders stay soft and Q4 revenue sits near the bottom of the range, the Q3 beat was a number to fade, not a new base to capitalize.